glp 1 safety long term The GLP-1 Trap: Your Jumpstart Might Be a Forever Commitment GLP1 Receptor Agonists—Effects beyond Obesity
Description
So why are patients discontinuing their GLP-1 prescriptions
Patients typically start with a lower dose of Wegovy, which is gradually increased over 16-20 weeks to minimize potential side effects such as nausea, vomiting, and diarrhea
FDA approval for orforglipron in March 2026
Final cost determined by your pharmacy and insurance coverage
[DOI] [PMC free article] [PubMed] [Google Scholar] Moore A
doi:10.1007/s00018-012-1062-x 183
